日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis

骨髓中的IL-4信号通路驱动促肿瘤髓系造血

Nelson M LaMarche ,Samarth Hegde # ,Matthew D Park # ,Barbara B Maier ,Leanna Troncoso ,Jessica Le Berichel ,Pauline Hamon ,Meriem Belabed ,Raphaël Mattiuz ,Clotilde Hennequin ,Theodore Chin ,Amanda M Reid ,Iván Reyes-Torres ,Erika Nemeth ,Ruiyuan Zhang ,Oakley C Olson ,Deborah B Doroshow ,Nicholas C Rohs ,Jorge E Gomez ,Rajwanth Veluswamy ,Nicole Hall ,Nicholas Venturini ,Florent Ginhoux ,Zhaoyuan Liu ,Mark Buckup ,Igor Figueiredo ,Vladimir Roudko ,Kensuke Miyake ,Hajime Karasuyama ,Edgar Gonzalez-Kozlova ,Sacha Gnjatic ,Emmanuelle Passegué ,Seunghee Kim-Schulze ,Brian D Brown ,Fred R Hirsch ,Brian S Kim ,Thomas U Marron ,Miriam Merad

Outcomes Following SBRT vs. IMRT and 3DCRT for Older Patients with Stage IIA Node-Negative Non-Small Cell Lung Cancer > 5 cm

对于肿瘤直径大于 5 厘米的 IIA 期淋巴结阴性非小细胞肺癌老年患者,立体定向放射治疗 (SBRT) 与调强放射治疗 (IMRT) 和三维适形放射治疗 (3DCRT) 的疗效比较

Tran, Jessica H; Mhango, Grace; Park, Henry S; Marshall, Deborah C; Rosenzweig, Kenneth E; Wang, Qian; Wisnivesky, Juan P; Veluswamy, Rajwanth R

Adverse Events Following Limited Resection versus Stereotactic Body Radiation Therapy for Early Stage Lung Cancer

早期肺癌有限切除术与立体定向放射治疗术后不良事件比较

Wang, Qian; Stone, Kimberly; Kern, Jeffrey A; Slatore, Christopher G; Swanson, Scott; Blackstock, William Jr; Khan, Rabia Saeed; Smith, Cardinale B; Veluswamy, Rajwanth R; Chidel, Mark; Wisnivesky, Juan P

Immunotherapy Outcomes in Individuals With Non-Small Cell Lung Cancer and Poor Performance Status

非小细胞肺癌患者免疫治疗效果及一般状况

Veluswamy, Rajwanth; Hu, Liangyuan; Smith, Cardinale; Ji, Jiayi; Wang, Xiaoliang; Wisnivesky, Juan; Morillo, Jose; Kale, Minal S

Modulation of chemoimmunotherapy efficacy in non-small cell lung cancer by sex and histology: a real-world, patient-level analysis

性别和组织学类型对非小细胞肺癌化疗免疫疗法疗效的影响:一项基于真实世界患者水平的分析

Tuminello, Stephanie; Alpert, Naomi; Veluswamy, Rajwanth R; Kumar, Arvind; Gomez, Jorge E; Flores, Raja; Taioli, Emanuela

Real-World longitudinal practice patterns in the use of PD-1 and PD-L1 inhibitors as First-Line therapy in patients with Non-Small cell lung cancer in the United States

美国非小细胞肺癌患者一线治疗中PD-1和PD-L1抑制剂的真实世界纵向实践模式

Veluswamy, Rajwanth; Hirsch, Fred R; Taioli, Emanuela; Wisnivesky, Juan; Strauss, Ross; Harrough, Douglas; Tang, Boxiong; Barnes, Gisoo

The benefits and harms of adjuvant chemotherapy for non-small cell lung cancer in patients with major comorbidities: A simulation study

辅助化疗对合并严重并发症的非小细胞肺癌患者的益处和危害:一项模拟研究

Leiter, Amanda; Kong, Chung Yin; Gould, Michael K; Kale, Minal S; Veluswamy, Rajwanth R; Smith, Cardinale B; Mhango, Grace; Huang, Brian Z; Wisnivesky, Juan P; Sigel, Keith

Optimizing the use of adjuvant chemotherapy in non-small cell lung cancer patients with comorbidities

优化非小细胞肺癌合并症患者辅助化疗的应用

Bailey, Stacyann; Wang, Qian; Kong, Chung Yin; Stone, Kimberly; Veluswamy, Rajwanth; Bates, Susan E; Smith, Cardinale B; Wisnivesky, Juan P; Sigel, Keith

Analysis of Real-World Data to Investigate the Impact of Race and Ethnicity on Response to Programmed Cell Death-1 and Programmed Cell Death-Ligand 1 Inhibitors in Advanced Non-Small Cell Lung Cancers

通过对真实世界数据的分析,研究种族和民族对晚期非小细胞肺癌患者程序性死亡受体-1和程序性死亡配体-1抑制剂疗效的影响

Ayers, Kristin L; Mullaney, Tommy; Zhou, Xiang; Liu, Jane J; Lee, Kyeryoung; Ma, Meng; Jones, Scott; Li, Li; Redfern, Arielle; Jappe, Whitney; Liu, Zongzhi; Goldsweig, Howard; Yadav, Kamlesh K; Hahner, Nicholas; Dietz, Matthew; Zimmerman, Michelle; Prentice, Tony; Newman, Scott; Veluswamy, Rajwanth; Wisnivesky, Juan; Hirsch, Fred R; Oh, William K; Li, Shuyu D; Schadt, Eric E; Chen, Rong

Post-anticoagulant D-dimer is a highly prognostic biomarker of COVID-19 mortality

抗凝血后D-二聚体是COVID-19死亡率的重要预后生物标志物

Song, Xiaoyu; Ji, Jiayi; Reva, Boris; Joshi, Himanshu; Calinawan, Anna Pamela; Mazumdar, Madhu; Wisnivesky, Juan P; Taioli, Emanuela; Wang, Pei; Veluswamy, Rajwanth R